Kynurenines in the CNS: recent advances and new questions

L Vécsei, L Szalárdy, F Fülöp, J Toldi - Nature reviews Drug discovery, 2013 - nature.com
Various pathologies of the central nervous system (CNS) are accompanied by alterations in
tryptophan metabolism. The main metabolic route of tryptophan degradation is the …

[HTML][HTML] Kynurenine emerges from the shadows–Current knowledge on its fate and function

M Marszalek-Grabska, K Walczak, K Gawel… - Pharmacology & …, 2021 - Elsevier
Kynurenine (KYN), a main metabolite of tryptophan in mammals, is a direct precursor of
kynurenic acid, anthranilic acid and 3-hydroxykynurenine (3-HK). Under physiological …

The new '5-HT'hypothesis of depression: cell-mediated immune activation induces indoleamine 2, 3-dioxygenase, which leads to lower plasma tryptophan and an …

M Maes, BE Leonard, AM Myint, M Kubera… - Progress in neuro …, 2011 - Elsevier
This paper reviews the body of evidence that not only tryptophan and consequent 5-HT
depletion, but also induction of indoleamine 2, 3-dioxygenase (IDO) and the detrimental …

Kynurenine pathway metabolites in humans: disease and healthy states

Y Chen, GJ Guillemin - International journal of tryptophan …, 2009 - journals.sagepub.com
Tryptophan is an essential amino acid that can be metabolised through different pathways, a
major route being the kynurenine pathway. The first enzyme of the pathway, indoleamine-2 …

The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression: physiopathological implications

C Hilmas, EFR Pereira, M Alkondon… - Journal of …, 2001 - Soc Neuroscience
The tryptophan metabolite kynurenic acid (KYNA) has long been recognized as an NMDA
receptor antagonist. Here, interactions between KYNA and the nicotinic system in the brain …

Increased cortical kynurenate content in schizophrenia

R Schwarcz, A Rassoulpour, HQ Wu, D Medoff… - Biological …, 2001 - Elsevier
Background: Metabolites of the kynurenine pathway of tryptophan degradation may play a
role in the pathogenesis of several human brain diseases. One of the key metabolites in this …

Kynurenic acid in neurodegenerative disorders—Unique neuroprotection or double‐edged sword?

A Ostapiuk, EM Urbanska - CNS neuroscience & therapeutics, 2022 - Wiley Online Library
Aims The family of kynurenine pathway (KP) metabolites includes compounds produced
along two arms of the path and acting in clearly opposite ways. The equilibrium between …

The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders

TW Stone, LG Darlington - British journal of pharmacology, 2013 - Wiley Online Library
Understanding the neurochemical basis for cognitive function is one of the major goals of
neuroscience, with a potential impact on the diagnosis, prevention and treatment of a range …

Is there a role for immune-to-brain communication in schizophrenia?

GM Khandaker, R Dantzer - Psychopharmacology, 2016 - Springer
Schizophrenia is characterised by hallucinations, delusions, depression-like so-called
negative symptoms, cognitive dysfunction, impaired neurodevelopment and …

Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites

F Moroni - European journal of pharmacology, 1999 - Elsevier
The synthesis of NAD (or NADP) from tryptophan involves a series of enzymes and the
formation of a number of intermediates which are collectively calledkynurenines.'In the late …